Health1 day ago
Centauri Therapeutics Secures $5.1 Million for ABX-01 Trials
Centauri Therapeutics Limited, an innovative immunotherapy company, has received an additional $5.1 million from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator). This funding will support the advancement...
